International trade · 06/03/2019Updated: 10/17/2026 · 1 min read
U.S. International Trade Commission to Investigate Allegations of Trade Secret Misappropriation by Allergan
Summary
The U.S. International Trade Commission has been asked to investigate allegations that Allergan, a pharmaceutical company, misappropriated trade secrets related to botulinum toxin products, which could harm a domestic industry in the United States
Original source language: Federal Register — International Trade CommissionOpen original release →